Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan

Oncology

Volumn 58, Issue 4, 2000, Pages 280-285

  Lin, Jen Der ^a,b   Chao, Tzu Chieh ^a   Sun, Jui Hung ^a   Ho, Cheng ^a   Weng, Hsiao Fen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Analysis, multivariate; Iodide, radioactive; Radiotherapy, external; Thyroglobulin

Indexed keywords

THYROGLOBULIN;

ADULT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOCIOECONOMICS; SURVIVAL RATE; TAIWAN; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

EID: 0034024813     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012113     Document Type: Article

References (27)

1. Department of Health, ROC: Cancer Registry Annual Report 1995. Taipei, The Institute, 1998.
2. Mazzaferri EL, Young RL: Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-518.
3. Ruegemer JJ, Hay ID, Bergstrahl EJ, Ryan JJ, Offord KP, Gorman CA: Distant metastasis in differentiated thyroid carcinoma: A multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988;67:501-508.
4. Lin JD, Huang BY, Weng HF, Jeng LB, Hsueh C: Thyroid ultrasonography with the fine needle aspiration cytology in the diagnosis of thyroid cancer. J Clin Ultrasound 1997;25:111-118.
5. Lin JD, Huang HS, Chen SC, Chao TC: Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan. Otolaryngol Head Neck 1997;116:475-482.
6. Lin JD, Huang MJ, Chao TC, Weng HF, Hsueh C: Prevalence of thyroid cancer on the examination of 11,656 patients in one medical center. Cancer J 1997;10:217-221.
7. Dinneen SF, Valimaki MJ, Bergstrahl EJ, Goellner JR, Gorman CA, Hay ID: Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995;80:2041-2045.
8. Pitlik S, Kitzes R, Ben-Bassat M, Rosenfeld JB: Thyroid carcinoma presenting as a solitary skin metastasis. Cutis 1983;31:532-536.
9. Cancer Statistics review 1973-1987. Bethesda, US Department of Health and Human Services, Public Health Service, NIH, 1988, pp 1-39.
10. DeGroot LJ, Kaplan EL, McCormick M, Straus FH: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
11. Lin JD, Chao TC, Huang MJ, Weng HF, Tzen KY: Using the radioactive iodine for the thyroid remnant ablation in well differentiated thyroid carcinoma to replace the thyroid reoperation. Am J Clin Oncol 1998;21:77-81.
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:475-481.
13. Peto R, Pike MC, Armitage P: Design and analysis of randomized clinical trial requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
14. Cox DR: Regression models and life tables. J R Stat Soc 1972;34:197-219.
15. Samaan NA, Maheshwari YK, Nader S, Hill CS Jr, Schultz PN, Haynie TP, Hickey RC, Clak RL, Goepfert H, Ibanez ML, Litton CE: Impact of therapy for differentiated carcinoma of the thyroid: An analysis of 706 cases. J Clin Endocrinol Metab 1983;56:1131-1138.
16. Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H: Thyroid cancer in Iceland 1955-1984. Acta Endocrinol 1988; 118:566-572.
17. Simpson WJ, McKinney SE: Canadian survey of thyroid cancer. Can Med Assoc 1985;132: 925-931.
18. Chen KP, Lee TY, Hsu PY, Sung CC, Chen CY, Chou HM, Hung HC: Study on the effect of salt iodization on endemic goiter, Taiwan. I. Mass survey on goiter of school children (in Chinese). J Formos Med Assoc 1976;75:471-482.
19. Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T: Papillary and follicular thyroid cancer-prognostic factors in 1578 patients. Am J Med 1987;83:479-488.
20. DeGroot LJ, Kaplan EL, McCormick M, Straus FH: Nature history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
21. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J: Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805-828.
22. Tubiana M, Schlumberger M, Rougier P, Laplanche A, Benhamon E, Gardet P, Caillou B, Travagli JP, Parmentier C: Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55: 794-804.
23. Woolner LB: Thyroid carcinoma: Pathologic classification with data on prognosis. Semin Nucl Med 1971;1:481-502.
24. Schindler AM, van Melle G, Evequoz B, Scazziga B: Prognostic factors in papillary carcinoma of the thyroid. Cancer 1991;68:324-330.
25. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF: Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic finding, therapy, and outcome. Mayo Clin Proc 1986;61:978-996.
26. Harvey RD, Matheson NA, Grabowski PS, Rodger AB: Measurement of serum thyroglobulin is of value in detecting tumor recurrence following treatment of differentiated thyroid carcinoma by lobectomy. Br J Surg 1990;77: 324-326.
27. Ozata M, Suzuki S, Miyamoto T, Liu RT, Fierro-Renoy F, DeGroot LJ: Serum thyroglobulin the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 1994;79:98-105.